urea has been researched along with Injury, Myocardial Reperfusion in 14 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Landiolol has a cardioprotective effect on I/R injury in the rat heart when administered before ischemia." | 5.34 | Pre-ischemic administration of landiolol prevents ischemia-reperfusion injury in the rat heart. ( Hirai, H; Minamiyama, Y; Sakaguchi, M; Sasaki, Y; Shibata, T; Suehiro, S; Takahashi, Y; Takemura, S, 2007) |
| " There were no significant differences in adverse events at 24 h between the landiolol and control groups." | 3.01 | Efficacy and Safety of Early Intravenous Landiolol on Myocardial Salvage in Patients with ST-segment Elevation Myocardial Infarction before Primary Percutaneous Coronary Intervention: A Randomized Study. ( Ichikawa, K; Ito, H; Miyamoto, M; Miyoshi, T; Mori, A; Nakamura, K; Oka, T; Osawa, K; Yoshikawa, M, 2021) |
| "Uremia was induced by partial nephrectomy in male Wistar rats." | 1.38 | Preconditioning protects the heart in a prolonged uremic condition. ( Bencsik, P; Csonka, C; Csont, T; Ferdinandy, P; Kocsis, GF; Pálóczi, J; Pipicz, M; Sárközy, M; Varga, ZV, 2012) |
| "Landiolol has a cardioprotective effect on I/R injury in the rat heart when administered before ischemia." | 1.34 | Pre-ischemic administration of landiolol prevents ischemia-reperfusion injury in the rat heart. ( Hirai, H; Minamiyama, Y; Sakaguchi, M; Sasaki, Y; Shibata, T; Suehiro, S; Takahashi, Y; Takemura, S, 2007) |
| " All three beta blockers were equally protective but the intermediate dosage of landiolol preserved LVP during the pre-ischemic period." | 1.32 | Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts. ( Fujita, S; Kanaya, N; Kurosawa, S; Nakayama, M; Namiki, A; Niiyama, Y, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Miyamoto, M | 1 |
| Osawa, K | 1 |
| Miyoshi, T | 1 |
| Mori, A | 1 |
| Yoshikawa, M | 1 |
| Oka, T | 1 |
| Ichikawa, K | 1 |
| Nakamura, K | 1 |
| Ito, H | 1 |
| Motoki, A | 1 |
| Merkel, MJ | 1 |
| Packwood, WH | 1 |
| Cao, Z | 1 |
| Liu, L | 1 |
| Iliff, J | 1 |
| Alkayed, NJ | 1 |
| Van Winkle, DM | 1 |
| Chaudhary, KR | 1 |
| Abukhashim, M | 1 |
| Hwang, SH | 1 |
| Hammock, BD | 1 |
| Seubert, JM | 1 |
| Yu, S | 1 |
| Katoh, T | 1 |
| Okada, H | 1 |
| Makino, H | 1 |
| Mimuro, S | 1 |
| Sato, S | 1 |
| Yoshitake, I | 1 |
| Hata, M | 1 |
| Sezai, A | 1 |
| Unosawa, S | 1 |
| Wakui, S | 1 |
| Kimura, H | 1 |
| Nakata, K | 1 |
| Hata, H | 1 |
| Shiono, M | 1 |
| Kocsis, GF | 1 |
| Sárközy, M | 1 |
| Bencsik, P | 1 |
| Pipicz, M | 1 |
| Varga, ZV | 1 |
| Pálóczi, J | 1 |
| Csonka, C | 1 |
| Ferdinandy, P | 1 |
| Csont, T | 1 |
| Kurosawa, S | 1 |
| Kanaya, N | 2 |
| Niiyama, Y | 1 |
| Nakayama, M | 2 |
| Fujita, S | 1 |
| Namiki, A | 2 |
| Ebel, D | 1 |
| Redler, S | 1 |
| Preckel, B | 1 |
| Schlack, W | 1 |
| Thämer, V | 1 |
| Mieno, S | 1 |
| Horimoto, H | 1 |
| Kishida, K | 1 |
| Horimoto, S | 1 |
| Sasaki, S | 1 |
| Takahashi, Y | 1 |
| Shibata, T | 1 |
| Sasaki, Y | 1 |
| Hirai, H | 1 |
| Takemura, S | 1 |
| Minamiyama, Y | 1 |
| Sakaguchi, M | 1 |
| Suehiro, S | 1 |
| Prosser, HC | 1 |
| Forster, ME | 1 |
| Richards, AM | 1 |
| Pemberton, CJ | 1 |
| Kimura-Kurosawa, S | 1 |
| Kamada, N | 1 |
| Hirata, N | 1 |
| Massoudy, P | 1 |
| Hartl, H | 1 |
| Zahler, S | 1 |
| Braun, S | 1 |
| Barankay, A | 1 |
| Becker, BF | 1 |
| Meisner, H | 1 |
| Wang, X | 1 |
| Wu, L | 1 |
| Aouffen, M | 1 |
| Mateescu, MA | 1 |
| Nadeau, R | 1 |
| Wang, R | 1 |
2 trials available for urea and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Efficacy and Safety of Early Intravenous Landiolol on Myocardial Salvage in Patients with ST-segment Elevation Myocardial Infarction before Primary Percutaneous Coronary Intervention: A Randomized Study.
Topics: Administration, Intravenous; Adrenergic beta-Antagonists; Aged; Female; Humans; Magnetic Resonance I | 2021 |
[Plasma lactate concentration in post-ischemic reperfusion of human hearts under treatment with sodium nitroprusside].
Topics: Aged; Anesthesia; Biomarkers; Chromatography, High Pressure Liquid; Female; Glutathione; Humans; Lac | 1999 |
12 other studies available for urea and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo.
Topics: 8,11,14-Eicosatrienoic Acid; Adamantane; Animals; Disease Models, Animal; Enzyme Inhibitors; Epoxide | 2008 |
Inhibition of soluble epoxide hydrolase by trans-4- [4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is protective against ischemia-reperfusion injury.
Topics: Animals; Arachidonic Acid; Benzoates; Dose-Response Relationship, Drug; Eicosanoids; Epoxide Hydrola | 2010 |
Landiolol does not enhance the effect of ischemic preconditioning in isolated rat hearts.
Topics: Adrenergic beta-Antagonists; Animals; Dose-Response Relationship, Drug; Heart; Hemodynamics; Ischemi | 2010 |
The effect of combined treatment with Impella(®) and landiolol in a swine model of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Animals; Combined Modality Therapy; Disease Models, Animal; Heart; Hear | 2012 |
Preconditioning protects the heart in a prolonged uremic condition.
Topics: Angiotensin II; Animals; Biomarkers; Creatinine; Disease Models, Animal; Ischemic Preconditioning, M | 2012 |
Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts.
Topics: Adrenergic beta-Antagonists; Animals; Guinea Pigs; Heart; In Vitro Techniques; Male; Morpholines; My | 2003 |
Moderate glucose deprivation preconditions myocardium against infarction.
Topics: Animals; Glucose; Myocardial Infarction; Myocardial Reperfusion; Myocardial Reperfusion Injury; Myoc | 2005 |
Landiolol enhances effect of ischemic preconditioning in isolated rabbit hearts.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Heart; Ischemic Preconditioning, Myocardia | 2006 |
Pre-ischemic administration of landiolol prevents ischemia-reperfusion injury in the rat heart.
Topics: Adrenergic beta-Antagonists; Animals; Dose-Response Relationship, Drug; Heart; Ischemic Precondition | 2007 |
Urotensin II and urotensin II-related peptide (URP) in cardiac ischemia-reperfusion injury.
Topics: Animals; Atrial Natriuretic Factor; Coronary Vessels; Creatine Kinase, MB Form; Humans; Male; Myocar | 2008 |
Cardioprotective effect and mechanism of action of landiolol on the ischemic reperfused heart.
Topics: Adrenergic beta-Antagonists; Animals; Calcium; Calcium-Binding Proteins; Cardiotonic Agents; Guinea | 2007 |
Novel cardiac protective effects of urea: from shark to rat.
Topics: Animals; Dogfish; Electrolysis; Female; Heart; In Vitro Techniques; Male; Methylamines; Myocardial R | 1999 |